SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-19-001627
Filing Date
2019-05-09
Accepted
2019-05-09 17:54:08
Documents
1
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4500
  Complete submission text file 0000930413-19-001627.txt   6047
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address SUITE 300, 5 PLACE VILLE MARIE MONTREAL A8 H3B 5E7
Business Address SUITE 300, 5 PLACE VILLE MARIE MONTREAL A8 H3B 5E7 514-283-0869
BDC CAPITAL INC. (Reporting) CIK: 0001430885 (see all company filings)

State of Incorp.: A8 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-38899 | Film No.: 19812044